ReviewKidney international supplements2018
Global capacity for clinical research in nephrology: a survey by the International Society of Nephrology.
Review in Kidney international supplements, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
10 citing papers in PubMed.
- Barriers to Research and Quality Improvement in Nephrology: Nurses and Allied Health Professionals' Perspectives.Journal of renal care · 2026Article
- Non-traditional barriers to participation in pharmacologic chronic kidney disease clinical trials.BMC nephrology · 2025Article
- Comprehensive epidemiological analysis of chronic kidney disease in adolescents and young adults (ages 10-24 years) from 1990 to 2021.BMJ open · 2025Article
- Global, regional, and National Burden of chronic kidney disease attributable to dietary risks from 1990 to 2021.Frontiers in nutrition · 2025Article
- Framework of Guidelines for Management of CKD in Asia.Kidney international reports · 2024Article
- Disparities in COVID-19 clinical studies from high-income and low-and middle-income countries.International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases · 2023Article
- Global Kidney Health Atlas: a spotlight on the Asia-Pacific sector.Kidney research and clinical practice · 2022Article
- Socioeconomic Determinants, Regional Differences, and Quality of Nephrology Research in Africa.Kidney international reports · 2020Article
- Nephrology in South Africa: Not YetKidney diseases (Basel, Switzerland) · 2019Review
- Building blocks toward sustainable kidney care around the world: results from a multinational survey by the International Society of Nephrology.Kidney international supplements · 2018Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
30 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Due to the worldwide rising prevalence of chronic kidney disease (CKD), there is a need to develop strategies through well-designed clinical studies to guide decision making and improve delivery of care to CKD patients. A cross-sectional survey was conducted based on the International Society of Nephrology Global Kidney Health Atlas data. For this study, the survey assessed the capacity of various countries and world regions in participating in and conducting kidney research. Availability of national funding for clinical trials was low (27%,
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.